A BODIPY‐Ferrocene Conjugate for the Combined Photodynamic Therapy and Chemodynamic Therapy with Improved Antitumor Efficiency
Chemistry – A European Journal · 2024
DOI: 10.1002/chem.202401916 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2024. Verfasst von Bin Yuan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Advanced Light Conversion Materials and Biophotonics, School of Chemistry and Life Resources, Renmin University of China, Beijing, …. Hauptthemen laut MEDLINE: Ferrous Compounds, Metallocenes, Photochemotherapy, Boron Compounds. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, research funding of Renmin University of China, Renmin University of China.
Abstract (Originalsprache)
Photodynamic therapy (PDT) can destroy tumor cells by generating singlet oxygen ( 1 O 2 ) under light irradiation, which is limited by the hypoxia of the neoplastic tissue. Chemodynamic therapy (CDT) can produce toxic hydroxyl radical (⋅OH) to eradicate tumor cells by catalytic decomposition of endogenous hydrogen peroxide (H 2 O 2 ), the therapeutic effect of which is highly dependent on the concentration of H 2 O 2 . Herein, we propose a BODIPY‐ferrocene conjugate with a balanced 1 O 2 and ⋅OH generation capacity, which can serve as a high‐efficiency antitumor agent by combining PDT and CDT. The ferrocene moieties endow the as‐prepared conjugates with the ability of chemodynamic killing of tumor cells. Moreover, combined PDT/CDT therapy with improved antitumor efficiency can be realized after exposure to light irradiation. Compared with the monotherapy by PDT or CDT, the BODIPY‐ferrocene conjugates can significantly increase the intracellular ROS levels of the tumor cells after light irradiation, thereby inducing the tumor cell apoptosis at low drug doses. In this way, a synergistic antitumor treatment is achieved by the combination of PDT and CDT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Advanced Light Conversion Materials and Biophotonics, School of Chemistry and Life Resources, Renmin University of China, Beijing, 100872, China.
- Key Lab of Organic Optoelectronics & Molecular Engineering, Department of Chemistry, Tsinghua University, Beijing, 100084, China.
ORCID-Profile: Bin Yuan
Förderung
- National Natural Science Foundation of China
- research funding of Renmin University of China
- Renmin University of China
Zitieren
APA
Yuan, B., Zhang, W., Wang, H., Xu, J. F., & Zhang, X. (2024). A BODIPY‐Ferrocene Conjugate for the Combined Photodynamic Therapy and Chemodynamic Therapy with Improved Antitumor Efficiency. Chemistry – A European Journal. https://doi.org/10.1002/chem.202401916
Vancouver
Yuan B, Zhang W, Wang H, Xu JF, Zhang X. A BODIPY‐Ferrocene Conjugate for the Combined Photodynamic Therapy and Chemodynamic Therapy with Improved Antitumor Efficiency. Chemistry – A European Journal. 2024. doi:10.1002/chem.202401916
BibTeX
@article{Yuan2024,
author = {Yuan, Bin and Zhang, Wenhui and Wang, Hua and Xu, Jiang-Fei and Zhang, Xi},
title = {A BODIPY‐Ferrocene Conjugate for the Combined Photodynamic Therapy and Chemodynamic Therapy with Improved Antitumor Efficiency},
journal = {Chemistry – A European Journal},
year = {2024},
doi = {10.1002/chem.202401916}
}
EUVIMED